20150 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Wall or coating material Organic macromolecular compounds
Sub-classes:ENCAPSULATION METHOD AND PARTICLE
#2THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR DRUG DELIVERY
#3IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES
#4LIPIDS, FORMULATIONS, AND USES THEREOF
#5LOW SODIUM OXYBATE ONCE NIGHTLY COMPOSITION
#6PHARMACEUTICAL COMPOSITIONS OF MIFEPRISTONE
#7MICROSPHERES WITH FLOW THROUGH VOIDS AS EMBOLIC AND DRUG DELIVERY AGENTS
#8Pharmaceutical compositions of mifepristone
#9METHODS FOR PROMOTING ANTI-TUMOR IMMUNE RESPONSE IN A SUBJECT IN NEED THEREOF USING ENCAPSULATED INTERLEUKIN 12
#10MEDICAMENT-CONTAINING HOLLOW PARTICLE
#11METHODS OF FABRICATING HYPER COMPLIANT POLYMER PARTICLES AND METHODS OF USE AND COMPOSITIONS
#12Pharmaceutical compositions of mifepristone
#13Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
#14COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#15THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR DRUG DELIVERY
#16MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#17Duloxetine sprinkles
#18Crystalline forms of therapeutic compounds and uses thereof
#19MOISTURE RESISTANT PROBIOTIC GRANULE AND METHODS OF PRODUCING THE SAME
#20MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#21Duloxetine sprinkles
#22MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#23Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
#24A HEPATOCYTE-MIMICKING ANTIDOTE FOR ALCOHOL INTOXICATION
#25METHOD FOR PREPARING PARTICLES COMPRISING METAL OXIDE COATING AND PARTICLES WITH METAL OXIDE COATING
#26Crystalline forms of therapeutic compounds and uses thereof
#27Amphiphile-Polymer Particles
#28Modified release formulations containing drug-ion exchange resin complexes
#29Duloxetine sprinkles
#30FORMULATION FOR PROTECTION THROUGH CONTROLLED RELEASE OF MICROPARTICLES CONTAINING RECOMBINANT OUTER MEMBRANE VESICLES
#31Microparticles
#32Methods for treating cryptosporidiosis using triazolopyridazines
#33Methods of fabricating hyper compliant polymer particles and methods of use and compositions
#34PHARMACEUTICAL COMPOSITION, PROCESS FOR PRODUCING THE SAME, USE OF A PEPTIDE, USE OF A PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DISEASES ASSOCIATED WITH INTRAOCULAR HYPERTENSION OR GLAUCOMA
#35COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#36EXTENDED RELEASE DRUG FORMULATION WITH OVERDOSE PROTECTION AND ABUSE DETERRENCE
#37MEDICAMENT-CONTAINING HOLLOW PARTICLE
#38Microparticles
#39MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#40Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
#41Modified release formulations containing drug-ion exchange resin complexes
#42Formation of a janus microcapsule
#43Crystalline forms of therapeutic compounds and uses thereof
#44Products containing charged polymer complex microcapsules and method of use
#45Bioerodible contraceptive implant and methods of use thereof
#46DULOXETINE SPRINKLES
#47COMPOSITIONS OF MULTICATIONIC DRUGS FOR REDUCING INTERACTIONS WITH POLYANIONIC BIOMOLECULES AND METHODS OF USE THEREOF
#48Duloxetine sprinkles
#49Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds
#50Methods for treating cryptosporidiosis using triazolopyridazines
#51Crystalline forms of therapeutic compounds and uses thereof
#52MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#53Microcapsules comprising a water-immiscible core and a wall comprising the salt of a lewis acid and a lewis base
#54Amphiphile-polymer particles
#55Modified release formulations containing drug-ion exchange resin complexes
#56Microcapsules formed from phosphate esters and compositions containing same
#57Methods of forming a slurry with microcapsules formed from phosphate esters
#58TREATMENT OF RETT SYNDROME
#59ANTIBIOTIC PROTOCELLS AND RELATED PHARMACEUTICAL FORMULATIONS AND METHODS OF TREATMENT
#60Modified release formulations containing drug-ion exchange resin complexes
#61Modified release formulations containing drug-ion exchange resin complexes
#62Modified release formulations containing drug - ion exchange resin complexes
#63COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#64Modified release formulations containing drug-ion exchange resin complexes
#65Lignin microcapsule and method of producing the same
#66Crystalline forms of therapeutic compounds and uses thereof
#67Transscleral drug delivery
#68Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery
#69DRUG DELIVERY SYSTEMS AND RELATED METHODS OF USE
#70Coated titanium dioxide to reduce the whitening effect on skin
#71Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
#72Crystalline forms of therapeutic compounds and uses thereof
#73Modified release formulations containing drug—ion exchange resin complexes
#74PHARMACEUTICAL PRODUCT TO INDUCE ENDOGENOUS EXACERBATED RELEASE OF GUT HORMONES PYY AND GLP1 WITH THERAPEUTIC EFFECT ON OBESITY AND TYPE 2 DIABETES MELLITUS
#75Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof
#76Modified release formulations containing drug-ion exchange resin complexes
#77ANTI-MISUSE MICROPARTICULATE ORAL PHARMACEUTICAL FORM
#78Modified release formulations containing drug-ion exchange resin complexes
#79Modified release formulations containing drug-ion exchange resin complexes
#80TDF-related compounds and analogs thereof, analogs and bioactive fragments
#81Compositions and methods for delivery of poorly soluble drugs
#82Modified release formulations containing drug-ion exchange resin complexes
#83Anti-fouling materials based on poly(β-peptoid)s
#84Method for producing pancreatin pellets
#85Methods For Improved Cryo-Chemotherapy Tissue Ablation
#86Modified release formulations containing drug-ion exchange resin complexes
#87Nanoparticles for drug delivery to the central nervous system
#88Methods and compositions for treating phenylketonuria
#89MULTIMODAL THERAPEUTIC HYBRID PARTICLE COMPLEX AND SYSTEM
#90PARTICLES WITH INDUCIBLE CHANGE OF SHAPE
#91TDF-related compounds and analogs thereof, analogs and bioactive fragments
#92Nanoparticles for cytoplasmic drug delivery to cancer cells
#93Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
#94Modified release formulations containing drug-ion exchange resin complexes
#95Anti-misuse microparticulate oral pharmaceutical form
#96Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides
#97METHOD FOR PREPARING PARTICLES COMPRISING METAL OXIDE COATING AND PARTICLES WITH METAL OXIDE COATING
#98Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#99Compositions and methods for delivery of poorly soluble drugs
#100PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY
#101Methods for improved cryo-chemotherapy tissue ablation
#102Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel process for preparing other forms
#103Anti-misuse microparticulate oral pharmaceutical form
#104Modified release formulations containing drug-ion exchange resin complexes
#105Composition and method for neuromuscular blockade
#106Microparticles
#107Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
#108Asymmetrically coated table
#109Composition and method for treating neurological disease
#110Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#111Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#112Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#113Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#114Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#115Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#116Modified release composition for highly soluble drugs
#117Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#118Processes for preparing amorphous atorvastatin hemi-calcium
#119Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#120Processes for preparing amorphous atorvastatin hemi-calcium
#121Processes for preparing amorphous atorvastatin hemi-calcium
#122Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#123Delayed and sustained drug release
#124Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
#125Duloxetine sprinkles